Market evolution: Oxygen-function amino compounds (CN 292250) — 2015–2025
Introduction
This report examines the evolution of EU extra-EU trade in goods classified under Combined Nomenclature code 292250 — a residual sub-heading within the oxygen-function amino-compounds family (CN 2922) that covers amino-alcohol-phenols, amino-acid-phenols, and other amino-compounds with oxygen function not elsewhere specified. The product category intersects with pharmaceutical intermediates, agrochemical building-blocks and specialty chemical applications. Over the 2015–2025 period, the EU's trade position in this product class has undergone a structural transformation: the Union shifted from a comfortable trade surplus to a pronounced deficit, driven primarily by the collapse of a single large export channel and the simultaneous surge of import volumes from Asia. The analysis draws on annual customs data and highlights three principal dynamics: the implosion of EU exports, the growing reliance on Chinese and Indian suppliers, and a reshaping of the EU's internal specialisation landscape.
1. The collapse of EU exports and the swing into a trade deficit
The most striking feature of the 2015–2025 period is the dramatic erosion of EU export performance, which turned the bloc's trade balance decisively negative.
EU exports fell by two-thirds in value while volumes declined only modestly
EU exports of CN 292250 to non-EU countries dropped from EUR 705 million (first period) to EUR 243 million (last period), a decline of 65.6%. Over the same span, exported quantity fell only 19.3% — from 31,903 tonnes to 25,741 tonnes. The gap between the value and volume declines is explained by a 57.5% collapse in unit export prices, from EUR 22,079/t to EUR 9,389/t. This suggests that the EU lost high-value export markets and increasingly shipped lower-priced product, or that global pricing pressure intensified considerably.
| Metric | First period | Last period | Change (%) |
|---|---|---|---|
| Export value (EUR) | 704,728,516 | 242,686,342 | −65.6% |
| Export quantity (t) | 31,903 | 25,741 | −19.3% |
| Export unit price (EUR/t) | 22,079 | 9,389 | −57.5% |
The United States channel — once dominant — has nearly vanished
The overwhelming driver of the export collapse was the near-disappearance of EU-to-US shipments. In the first period, the United States absorbed EUR 458 million worth of EU exports of CN 292250 — accounting for roughly 65% of all extra-EU export value. By the last period this had plummeted to just EUR 52 million (−88.7%). Brazil also saw a steep decline, from EUR 15.5 million to EUR 2.2 million (−86.0%). The loss of these two Western Hemisphere markets alone accounts for the majority of the overall export contraction.
| Destination | First period (EUR) | Last period (EUR) | Change (%) |
|---|---|---|---|
| United States | 458,185,235 | 51,583,913 | −88.7% |
| United Kingdom | 43,821,790 | 18,407,693 | −58.0% |
| Brazil | 15,502,106 | 2,177,024 | −86.0% |
| Türkiye | 9,992,985 | 5,041,458 | −49.6% |
| India | 26,643,713 | 43,525,835 | +63.4% |
| Mexico | 16,079,025 | 14,202,916 | −11.7% |
Ireland's export implosion mirrors the structural shift
On the EU reporter side, Ireland was by far the largest exporter in the first period, shipping EUR 461 million worth of product abroad — almost entirely destined for the United States. By the last period, Irish exports had collapsed to EUR 1.4 million (−99.7%). This aligns with the loss of the US channel and is consistent with the relocation or restructuring of pharmaceutical and fine-chemical manufacturing in Ireland during this decade. Other major exporting Member States — Germany, Spain, Italy — experienced more moderate declines of 4% to 29%, while Denmark (+39.2%) and the Netherlands (+370.0%) bucked the trend and grew.
| EU reporter | First period (EUR) | Last period (EUR) | Change (%) |
|---|---|---|---|
| Ireland | 460,733,212 | 1,387,563 | −99.7% |
| Germany | 46,888,094 | 33,195,162 | −29.2% |
| Spain | 44,544,795 | 38,543,644 | −13.5% |
| Italy | 34,451,843 | 32,963,296 | −4.3% |
| Denmark | 29,425,954 | 40,964,270 | +39.2% |
| Netherlands | 9,115,354 | 42,840,789 | +370.0% |
The trade balance swung from a EUR 262 million surplus to a EUR 291 million deficit
As a combined result of export collapse and import growth, the EU's trade balance in CN 292250 reversed from +EUR 262 million in the first period to −EUR 291 million in the last period — a swing of −210.8%. The deficit peaked at −EUR 528 million at one point during the period. This places the EU as a net importer of these compounds, a fundamentally different position from a decade earlier.
2. Surging import volumes from Asia at declining prices
While EU exports contracted, imports expanded dramatically in volume, reshaping the supply side of the market.
Import volumes more than doubled while values grew only modestly
EU imports of CN 292250 rose from 76,702 tonnes in the first period to 185,468 tonnes in the last — an increase of 141.8%. In value terms, however, imports grew only 20.5% (from EUR 442 million to EUR 533 million). This divergence reflects a 50.2% decline in import unit prices, from EUR 5,767/t to EUR 2,874/t. The combination of rising volumes and falling prices is characteristic of expanding low-cost Asian supply, particularly from China and India.
| Metric | First period | Last period | Change (%) |
|---|---|---|---|
| Import value (EUR) | 442,432,125 | 533,218,371 | +20.5% |
| Import quantity (t) | 76,702 | 185,468 | +141.8% |
| Import unit price (EUR/t) | 5,767 | 2,874 | −50.2% |
China consolidated its position as the dominant supplier
China remained the EU's single largest source of imports throughout the period, growing from EUR 183 million to EUR 307 million (+68.0%). At its peak, Chinese imports reached EUR 523 million, underlining the extent to which EU dependence on Chinese supply deepened. India, the second-largest supplier, nearly doubled its share from EUR 46 million to EUR 88 million (+90.1%). Together, China and India accounted for the vast majority of import growth.
| Supplier | First period (EUR) | Last period (EUR) | Change (%) |
|---|---|---|---|
| China | 182,539,339 | 306,750,290 | +68.0% |
| India | 46,320,587 | 88,063,401 | +90.1% |
| United Kingdom | 16,722,020 | 39,382,241 | +135.5% |
| Switzerland | 32,805,361 | 42,012,902 | +28.1% |
| Japan | 20,742,912 | 28,330,689 | +36.6% |
| United States | 10,123,564 | 14,043,993 | +38.7% |
| Israel | 7,481,191 | 135,334 | −98.2% |
EU import concentration intensified, reflecting growing dependence on a few suppliers
The Herfindahl–Hirschman Index (HHI) for import value rose from 2,676 to 3,778 (+41.2%), indicating that the EU's import base became significantly more concentrated. While an HHI of 2,676 already signals moderate concentration, a reading of 3,778 approaches high concentration territory. This is largely a consequence of China's growing dominance. By contrast, export-side HHI fell from 4,339 to 1,407 (−67.6%), reflecting the collapse of the formerly dominant Ireland-to-US corridor and a more diversified — though much smaller — export base.
| HHI (value) | First period | Last period | Change (%) |
|---|---|---|---|
| Imports | 2,676 | 3,778 | +41.2% |
| Exports | 4,339 | 1,407 | −67.6% |
EU domestic production grew, yet failed to keep pace with import demand
EU PRODCOM production of oxygen-function amino-compounds increased from 292,818 tonnes to 350,000 tonnes (+19.5%) in volume and from EUR 1.30 billion to EUR 1.49 billion (+14.1%) in value. While this confirms that the EU retained a sizeable domestic production base, the 19.5% production growth is dwarfed by the 141.8% growth in import volumes — suggesting that a significant share of incremental demand was met by foreign suppliers.
3. Shifting specialisation patterns and emerging supply-chain vulnerabilities
Behind the headline trade figures lie important structural changes in which Member States specialise in this product and how exposed the EU is to external supply disruptions.
Ireland retained the highest revealed comparative advantage despite losing its export base
In the most recent period, Ireland still registers the highest Revealed Symmetric Comparative Advantage (RSCA) at 0.68, reflecting its historically dominant position. However, with exports now at barely EUR 1.4 million, this is largely a residual signal. Spain (RSCA 0.40), Lithuania (0.47), Sweden (0.35), and Denmark (0.34) emerge as the more dynamically specialised exporters. These countries have either maintained or grown their exports over the period, suggesting genuine competitive positioning.
| Member State | RSCA (2025) | RCA (2025) | Share of EU product exports | Share of EU total exports |
|---|---|---|---|---|
| Ireland | 0.68 | 5.25 | 11.0% | 2.1% |
| Lithuania | 0.47 | 2.78 | 1.7% | 0.6% |
| Spain | 0.40 | 2.31 | 13.4% | 5.8% |
| Sweden | 0.35 | 2.08 | 5.0% | 2.4% |
| Denmark | 0.34 | 2.03 | 3.5% | 1.7% |
Net import reliance increased and peaked well above 60%
The EU's net import reliance rose from 32.6% to 40.6%, with a peak of 66.0% at some point during the period. This metric — defined as net imports as a share of apparent consumption — confirms that the EU is structurally dependent on external suppliers for a growing share of its CN 292250 needs. The trade intensity of the product also increased from 71.1% to 76.2%, indicating that the overall openness of this market relative to EU production remains elevated.
| Vulnerability indicator | First period | Last period | Change (pp) |
|---|---|---|---|
| Net import reliance (%) | 32.6 | 40.6 | +8.1 |
| Trade intensity (%) | 71.1 | 76.2 | +5.1 |
| Export propensity (%) | 44.4 | 48.4 | +4.0 |
Import-side volatility remained moderate but several export markets showed price shocks
Among export destinations, the highest year-to-year price volatility was recorded for Brazil (coefficient of variation 1.31), Norway (0.83), and Ukraine (0.64). The shock detection algorithm flagged three significant price shock events on the export side:
- Brazil (2018): export price shifted +621.6% with an abnormality score of 36.8.
- Russia (2019): export price shifted +633.8% with an abnormality score of 22.5.
- Israel (2023): export price shifted +142.7% with an abnormality score of 10.8.
These events are consistent with episodic, low-volume trade in niche product sub-types where a single shipment can sharply move the average price. On the import side, Türkiye showed the highest volatility (CV 2.02) and Switzerland (CV 1.42) and Israel (CV 1.31) also stood out — though their import volumes are comparatively small.
Conclusion
Over the 2015–2025 decade, the EU market for oxygen-function amino-compounds under CN 292250 underwent a profound structural rebalancing. The trade surplus of EUR 262 million turned into a deficit of EUR 291 million, driven principally by the near-total loss of exports to the United States — a channel that was dominated by Ireland and that was likely tied to specific pharmaceutical-intermediate supply chains. On the import side, Chinese and Indian suppliers capitalised on growing EU demand by expanding volumes by 142% at progressively lower prices, concentrating the EU's import base and pushing net import reliance above 40%. EU domestic production did grow (by ~20% in volume), but far less than the surge in import penetration.
These trends raise questions about supply-chain resilience, particularly given the growing concentration of imports from a small number of Asian origins. While the diversification of EU export destinations (with India, Denmark, and the Netherlands emerging as brighter spots) and the continued presence of multiple Member States with revealed comparative advantage suggest some adaptive capacity, the EU's strategic autonomy in this product class has clearly diminished over the period under review.